Effects of a Rehabilitation Treatment on Balance in PD Evaluated With a Stabilometric Platform
NCT ID: NCT02098707
Last Updated: 2014-03-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
30 participants
OBSERVATIONAL
2013-06-30
2014-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Analysis of the Parameters Obtained on Stabilometric Platform in Patients With PD
NCT02098655
Effectiveness of Intensive Rehabilitation in Advanced Stages of Parkinson's Disease.
NCT02731170
MIRT and Rotigotine in the Early Stage of PD
NCT02100176
Impact of Rehabilitation in Quality of Life in PD
NCT02756676
The Effect of a Motor-cognitive Rehabilitation on Attention in Parkinsonian Patients
NCT02727257
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
PD patients in stage 3 of Hoen \& Yahr will undergo clinical and instrumental evaluations at the beginning (T0) and at the end (T1) of the MIRT. Berg Balance Scale (BBS) will be performed to assess static and dynamic balance abilities. In order to determine some variables as index of postural stability, the investigators will use a stabilometric platform. With respect to the average centre of gravity the standard deviation (SD) of trunk sway will be calculated: total, in antero-posterior (AP) and in medio-lateral (ML) direction. The investigators can obtain a statokinesigram, that is the layout of a line connecting the successive positions of the center of pressure during the recording, and the area of the ellipse containing 90% of the sampled positions of the center of pressure. These measurements will be calculated with open eyes (OE), and while the patient was performing a cognitive task (open eyes counting \[OEC\]).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
30 Parkinson disease patients
30 patients (12 M, 18 F, mean age 66,8 ± 8,7) diagnosed with PD in stage 3 of Hoen\&Yahr (mean Unified Parkinson Disease Rating Scale \[UPDRS\] III 18.8±10.5) will undergo a balance training using a stabilometric platform.
Stabilometric Platform
Stabilometric platform is a device used for assessment and training of balance basing on ground reaction force evaluation in static conditions.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Stabilometric Platform
Stabilometric platform is a device used for assessment and training of balance basing on ground reaction force evaluation in static conditions.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
58 Years
74 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ospedale Generale Di Zona Moriggia-Pelascini
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Giuseppe Frazzitta, MD
Role: PRINCIPAL_INVESTIGATOR
Ospedale Generale di Zona "Moriggia-Pelascini", Gravedona ed Uniti (CO), Italy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ospedale Generale di Zona "Moriggia-Pelascini"
Gravedona, Como, Italy
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SPPD002
Identifier Type: OTHER
Identifier Source: secondary_id
SP PD 002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.